EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity

Zhiyun Liu, Lingyao Zeng, Xulin Gan, Yilin Zhou, Han Shen, Dan Wu, Xin Shou, Minmin Jiang, Liyun Shi iD

Advanced Science · 2026-06 · 13 (33)

DOI: 10.1002/advs.202520903 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 10.04.2026. Verfasst von Zhiyun Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Metabolic Reprogramming, Tumor Microenvironment, Tumor-Associated Macrophages, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Public Welfare Research Program of Zhejiang Province, Scientific Research Start-up Foundation of Zhejiang Shuren University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐associated macrophages (TAMs) are central regulators of the tumor microenvironment (TME), with their metabolic states critically influencing tumor progression or regression. Although reprogramming TAM metabolism is a promising therapeutic avenue, clinical translation remains challenging due to the oversimplified understanding of macrophage plasticity. To bridge these gaps, we first provide an in‐depth analysis of the metabolic signatures and functional heterogeneity of TAMs, highlighting key pathways—glycolysis, fatty acid oxidation, and amino acid metabolism—that govern TAM functional diversity. Building on this foundation, we offer a comprehensive overview of current therapeutic strategies targeting critical metabolic regulatory nodes in TAMs and explore future directions for their clinical translation. Ultimately, we propose that precisely modulating the metabolic networks of TAMs can effectively reprogram their immunosuppressive functions, thereby opening new avenues for advancing cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic ReprogrammingTumor MicroenvironmentTumor-Associated MacrophagesNeoplasmsImmunotherapyMacrophagesHumansAnimals

Stichwörter der Autor:innen

macrophage polarizationmetabolic reprogrammingtargeted drug deliverytumor microenvironmenttumor‐associated macrophages (TAMs)

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, China.
  • Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, China.
  • Yuhang Institute of Medical Science Innovation and Transformation, Zhejiang, Hangzhou, China.

ORCID-Profile: Liyun Shi

Förderung

  • National Natural Science Foundation of China
  • Basic Public Welfare Research Program of Zhejiang Province
  • Scientific Research Start-up Foundation of Zhejiang Shuren University
  • National Innovation and Entrepreneurship Training Program for College Students in 2024

Zitieren

APA

Liu, Z., Zeng, L., Gan, X., Zhou, Y., Shen, H., Wu, D., Shou, X., Jiang, M., & Shi, L. (2026). Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity. Advanced Science, 13(33). https://doi.org/10.1002/advs.202520903

Vancouver

Liu Z, Zeng L, Gan X, Zhou Y, Shen H, Wu D, et al. Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity. Advanced Science. 2026;13(33). doi:10.1002/advs.202520903

BibTeX
@article{Liu2026,
  author = {Liu, Zhiyun and Zeng, Lingyao and Gan, Xulin and Zhou, Yilin and Shen, Han and Wu, Dan and Shou, Xin and Jiang, Minmin and Shi, Liyun},
  title = {Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {33},
  doi = {10.1002/advs.202520903}
}
Kostenlos starten →